YY/T 1465.5-2016Immunogenic evaluation method of medical devices - Part 5: Determination of a-Gal antigen clearance in medical devices utilizing animal tissues and their derivatives with M86 antibody (English PDF)
医疗器械免疫原性评价方法第5部分:用M86抗体测定动物源性医疗器械中α-Gal抗原清除率
This is a limited preview
Buy now to download the full PDF (19 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1465.5-2016 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
July 29, 2016
Implementation date
June 1, 2017
Scope
YY/T 1465.5-2016 is the English-translated version of 医疗器械免疫原性评价方法第5部分:用M86抗体测定动物源性医疗器械中α-Gal抗原清除率.
YY/T 1465.5-2016 is the Chinese pharmaceutical industry standard that gives the method for determining, with the M86 antibody, how completely the alpha-Gal antigen has been cleared from a medical device made of animal tissue or of a derivative of it.
It is the fifth part of the YY/T 1465 series and sets out the preparation and sectioning of the samples, the antibody and the immunohistochemical staining, the groupings and controls of the test and the reading of the sections under the optical microscope. Issued on 29 July 2016, it has applied since 1 June 2017.
Found what you need?
Document preview — YY/T 1465.5-2016
National Standard of the People's Republic of China
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Foreword3
- Introduction4
- 1 General provisions5
- 2 Normative references5
- 3 Terms and definitions6
- 4 Test principle6
- 5 Reagents and instruments6
- 6 Test steps6
- 7 Data analysis9
- 8 Test report10
- Appendix A (Informative) Example of determination of alpha-Gal antigen clearance rate in enzymatically hydrolyzed pig skin products by immunohistochemistry11
- Appendix B (Informative) Example of sample processing14
- References16
1 General provisions
This Part of YY/T 1465 provides a method for determining the clearance rate of alpha-Gal antigen in medical devices of animal origin, which is suitable for the evaluation of the effectiveness of the alpha-Gal antigen clearance process.
The method in this Part is applicable to materials that can fully expose the alpha-Gal antigen through grinding. If the alpha-Gal antigen cannot be fully exposed through grinding, other confirmed suitable methods may be considered.
Note: Appendix A gives examples of immunohistochemistry evaluation methods.
2 Normative references
The following documents are essential to the application of this document. For the dated documents, only the versions with the dates indicated are applicable to this document; for the undated documents, only the latest version (including all the amendments) is applicable to this standard.
GB/T 16886.2 Biological evaluation of medical devices - Part 2: Animal welfare requirements (GB/T 16886.2-2011, ISO 10993-2:2006, IDT)
GB/T 16886.20 Biological evaluation of medical devices - Part 20: Principles and methods for immunotoxicology testing of medical devices (GB/T 16886.20-2015, ISO/TS 10993-20:2006, IDT)
YY/T 0771.1 Medical devices utilizing animal tissues and their derivatives - Part 1. Application of risk management (YY/T 0771.1-2009, ISO 22442-1:2007, IDT)
Chinese Pharmacopoeia 2010 Edition avoiding excessive destruction. The recommended particle size distribution range of the processed sample is (0 µm ~ 90 µm). Examples of different types of sample processing are given in Appendix B.
Note 1. Animal-derived biological materials are mainly composed of structural proteins, such as collagen fibers. Experimenters should use appropriate sample preparation methods, to ensure that the alpha-Gal antigen in the test sample is fully exposed.
Note 2. Three parallel samples are prepared for each sample; the average value is taken as the final measurement result.
Note 3. According to the request of the client, 3 samples of different batch numbers or the same batch number can be taken, to evaluate the process stability of different batches or the same batch.
6 Test steps
6.6 Indirect inhibition ELISA method to detect the remaining M86 antibodies in the supernatant solution Add excess alpha-Gal antigen solution, 100 µL/hole, to the corresponding holes of the 96- hole plate. Incubate at 4 °C overnight. Use washing solution to wash the plate three times. Take 100 µL of the supernatant prepared according to 6.5. Add it to the 96-hole plate coated with the corresponding antigen. After shaking and incubating at 37 °C for 2 hours, use the washing solution to wash the plate three times. Add HRP-labeled anti-mouse secondary antibody. Incubate with shaking at 37 °C for 1 hour. Then use the washing solution to wash the plate three times. After color development, read the absorbance value with a microplate reader.
6.2 Preparation of test system control materials
6.2.1 General
Considering that the methods in this standard are affected by many factors, appropriate control substances should be used, to verify the rationality of the test system before testing. It is recommended to use mouse myeloma (SP2/0) cells or rabbit red blood cells (RRBC). If other reference substances are selected, their effectiveness should be confirmed.
6.2.2 SP2/0 cells
SP2/0 (ATCC CRL-1581TM) is obtained from the fusion of spleen B cells of BALB/c mice immunized with sheep red blood cells and mouse myeloma cells. It does not secrete immunoglobulins. Use RPMI1640 complete medium to culture, until the growth state is good; adjust the cell concentration to 1 x 10^7 cells/mL for later use.
6.2.3 RRBC
6.2.3.1 It is recommended to use untested healthy New Zealand rabbits, SPF grade. If other strains of rabbits are selected, their suitability should be explained. Animals should be kept for at least 5 days before blood collection, to adapt to the laboratory environment. All animal testing should be conducted in laboratories approved by national accreditation agencies and in compliance with all applicable regulations on laboratory animal welfare, meanwhile it should also comply with the requirements of GB/T 16886.2.
6.2.3.2 Take 20 mL of fresh rabbit whole blood. Add it to an Erlenmeyer flask containing glass beads. Shake for 10 minutes, to remove fibrin. Add about 10 times the amount of 0.9% sodium chloride solution. Shake well. Centrifuge at 2000 r/min for 5 minutes. Remove the supernatant. Wash the precipitated red blood cells 3 times, using 0.9% sodium chloride solution, according to the above method, until the supernatant is no longer red. The obtained red blood cells are mixed with 0.9% sodium chloride solution to 1 x 10^7 cells/mL. Store it at 4 °C for later use.
6.2.4 Preparation steps
Resuspend 1 x 10^6 SP2/0 cells or RRBC in 40 µL of 1% BSA. Mix well. Dilute 20 µL of cells to create a total of 4 concentration gradients (including a blank group without cells). Add 1% BSA solution to the cell stock solution and diluent, respectively, 80 µL/tube. Then the volume ratio of the highest concentration group containing the cell stock solution is 20%. The volume ratio of the remaining groups decreases in a gradient with the doubling dilution. Three replicate holes for each concentration gradient are available for use.
6.3 Test grouping
Test grouping includes.
a) Material group without alpha-Gal antigen removal process;
b) Material group after alpha-Gal antigen removal process;
c) Negative control group, materials that do not contain alpha-Gal antigen;
d) Test solvent control group.
6.4 Determination of optimal M86 antibody dilution
6.4.1 General
There may be certain differences in the potency of different batches of M86 antibodies; the optimal dilution of each batch of M86 antibodies should be determined. Divide the commercially available M86 into appropriate volumes. Store it for later use.
6.4.2 Preparation of alpha-Gal antigen standard
Take alpha-Gal-BSA. Dissolve it in the coating solution at pH 9.6. Add it to the microplate, 100 µL/hole. The recommended final concentration is 1 µg/mL ~ 10 µg/mL. Coat overnight at 4 °C. Use 1% BSA sealed for later use.
6.4.3 Optimal dilution of M86 antibody
Add 100 µL of diluted M86 antibody solution to each microplate, for a total of 8 dilutions. The recommended initial dilution is 1.25. The dilution is between 1.25 and 1.3200. Mix well. Incubate with shaking at room temperature for 1.5 hours. Use washing solution to wash the plate three times. Add HRP-labeled anti-mouse secondary antibody. Incubate with shaking at 37 °C for 1 hour. Then use washing solution to wash the plate three times. After color development, use a microplate reader to read the absorbance value. Draw a reaction curve between the absorbance value and the corresponding M86 dilution. Take twice the concentration value of the dilution, that just enters the plateau area of the reaction curve, as the optimal dilution. Dilute the stored M86 antibody before each use.
6.5 M86 antibody co-incubation
Add 160 µL of the M86 antibody solution, at the dilution ratio determined in 6.4, to each control substance and each test tube, at the same initial concentration grouped according to 6.3, that is, the total volume of each reaction tube is 200 µL. Mix well.
Shake and incubate at 4 °C overnight. Centrifuge the tube at 10000 g for 5 minutes. Take the supernatant for later use.
7 Data analysis
7.1 First, perform 3 repeated measurements on the test system's control substance and test sample. Take the average absorbance value of the 3 measurements. Calculate the M86 binding inhibition rate (remaining M86 binding rate), according to formula (1). Where.
I - M86 binding inhibition rate; a - OD value of the material group that has undergone the alpha-Gal antigen removal process, the material group that has not been alpha-Gal antigen removed, the negative control or the test system control substance; b - OD value of solvent control.
7.2 Use the binding inhibition rate of the test system's control substance M86 (repeated measurements 3 times) and the corresponding dilution, to obtain the binding inhibition rate curve equation. R2 should not be less than 0.96.
Appendix A (Informative)
Example of determination of alpha-Gal antigen clearance rate in enzymatically hydrolyzed pig skin products by immunohistochemistry
A.1 Test principle
The specific M86 antibody is combined with the alpha-Gal antigen in the test sample and stained by immunohistochemistry. By comparing the degree of color development before and after the alpha-Gal antigen removal process, the clearance rate of the alpha-Gal antigen is calculated.
A.2 Reagents and instruments
A.2.1 Reagents
A.2.1.1 Neutral formalin
A.2.1.2 5%BSA.
A.2.1.3 Xylene
A.2.1.4 Mouse M86 antibody
A.2.1.5 PBS
A.2.1.6 Tissue repair solution
A.2.1.7 Ethanol
A.2.2 Instruments
A.2.2.1 Oven
A.2.2.2 Tissue sectioning equipment
A.2.2.3 Optical microscope
A.3 Experimental procedures
A.3.1 Sample preparation
Take the samples to be tested that have been preserved and fixed in formalin, embedded in conventional paraffin, sliced, baked in a 60 °C oven overnight for later use.
A.3.2 Test grouping
Carry out the test according to the following groupings (5 samples per group, 3 slices prepared in parallel for each sample).
a) For the negative control group, it is recommended to use tissues that do not contain alpha-Gal antigen, such as human acellular dermis or GGTA1 gene knockout pig skin.
b) Positive control group, which is pig skin sample without alpha-Gal antigen removal process.
c) Test sample group, which is pig skin sample with alpha-Gal antigen removed by enzymatic hydrolysis.
A.3.3 Test procedures
A.3.3.1 Slices are deparaffinized in conventional xylene and subject to gradient ethanol treatment.
A.3.3.2 Rinse with distilled water and soak in PBS, 5 minutes/time, 2 times in total.
A.3.3.3 Microwave repair for 10 minutes. First heat the repair solution to 95 °C ~ 100 °C. Then put in the slices.
A.3.3.4 Incubate with 3% hydrogen peroxide for 10 minutes at room temperature, to block the activity of endogenous peroxidase. A.3.3.5 Rinse with PBS, 5 min/time, 3 times in total. A.3.3.6 Block with 5% BSA solution for 30 minutes.
A.3.3.7 Add the appropriate dilution of M86 antibody determined in 6.4; incubate at 4 °C overnight.
A.3.3.8 Rinse the slices with PBS, 5 minutes/time, a total of 3 times.
A.3.3.9 Add the secondary antibody working solution according to the instructions.
Incubate at room temperature or 37 °C for 15 min ~ 20 min. Rinse the slices with PBS, 5 min/time, a total of 3 times.
A.3.3.10 DAB color development takes 3 min ~ 15 min. Rinse thoroughly with running water.
A.3.3.11 If necessary, the nuclei can be counterstained with hematoxylin (0.5% ~ 1%), dehydrated, transparent, sealed.
A.3.4 Test results
Appendix B (Informative) Example of sample processing
B.1 General
Sample processing should ensure full exposure of alpha-Gal antigen and avoid excessive destruction. It is recommended to use tissue homogenizer1) for sample processing.
Other equivalent processing methods can also be used; however, users should confirm the selected test parameters.
B.2 Sample processing
B.2.1 Bone samples
For bone implant samples, take 100 mg of the sample into a 1.5 mL grinding bottle.
Add eight 3 mm and one 5 mm ceramic magnetic beads. Rotate at 6800 r/min, 30 s/time.
Cool with liquid nitrogen and grind 2 or more times (interval time. 30 s), until the sample is completely crushed (particle size less than 100 µm). Place it on ice for later use. Take an appropriate amount of test sample. Weigh it accurately and record it. Put it into a 0.5 mL centrifuge tube. Add 0.1 mL of 1% BSA solution. Take the homogenate for doubling gradient dilution, at least 4 gradients. Take 40 µL each. Place it in a 0.5 mL centrifuge tube for later use.
B.2.2 Dry sample
Take an appropriate amount of test sample. Weigh it accurately and record it. Use sterile ophthalmic scissors to cut the sample into appropriate size. Put it into a 1.5 mL grinding bottle. Add 300 µL of 1% BSA solution. Add eight 3 mm and one 5 mm ceramic magnetic beads. The rotation speed is 6800 r/min, 30 s/time. Cool it with liquid nitrogen and grind it 2 or more times (interval time is 30 s), until the sample is completely crushed (the particle size is less than 100 µm) and a uniform tissue homogenate is formed. Take the homogenate and carry out doubling gradient dilution, for at least 4 gradients. Take 40 µL of each and place it in a 0.5 mL centrifuge tube for later use.
B.2.3 Wet sample
Take an appropriate amount of test sample. Place it in a 1.5 mL sterile centrifuge tube.
Vacuum dry or assist drying in a 37 °C drying oven. Then take the test sample (<= 300 µg). Weigh it accurately and record it. Use sterile ophthalmic scissors to cut the sample 1 BertinPrecellys24 is an example of a suitable commercially available product. This information is given for the convenience of users of this standard and does not imply endorsement of the product. Other equivalent products may be used if they have the same effect. […]
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 19 pages — is available in the English PDF.
Referenced standards
Normative references
- GB/T 16886.2Biological evaluation of medical devices - Part 2: Animal welfare requirements
- GB/T 16886.20Biological evaluation of medical devices-Part 20:Principles and methods for immunotoxicology testing of medical devices
- YY/T 0771.1Medical devices utilizing animal tissues and their derivatives - Part 1: Application of risk management
Similar standards
How to Download YY/T 1465.5-2016
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 16886.2-2011 — Biological evaluation of medical devices -- Part 2: Animal welfare requirements
GB/T 16886.2-2026 — Biological evaluation of medical devices - Part 2: Animal welfare requirements
GB/T 16886.20-2015 — Biological evaluation of medical devices-Part 20:Principles and methods for immunotoxicology testing of medical devices
Secure payment via Stripe
Payments accepted
YY/T 1465.5-2016
$175.00